Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Self-citationDNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Research works printed but not linked: 3
- CELL 78: 23 (1994).
- Nagy, A., Gene Targeting: A Practical Approach: 147 (1993).
- Wurst, W., Gene Targeting: A Practical Approach: 31 (1993).
Cited by
Items 801–885 of 885
Liu, A. Y. ‐., Mathew, A., Karim, C., Eshak, P., & Chen, K. Y. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.08.005
Fragile polyQ assemblies cause Golgipathy in Huntington’s diseasePreprint
Ma, L., Chen, X., Liu, Y., Dai, L., Ye, F., Yang, W., Buhe, H., Ma, J., Song, C., Li, L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.06.616845
Deubikvitináz gének hatásának vizsgálata a Huntington-kór Drosophila modelljében
Farkas, A. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12206
Kim, E., Vatsavayai, S. C., & Seeley, W. W. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.004
Transgenic Mouse Models of CAG Trinucleotide Repeat Neurologic Diseases
Orr, H. T., & Zoghbi, H. Y. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4887-4_8
Frühe Proteomveränderungen im Gehirn bei einem transgenen Rattenmodell für die Huntington-Erkrankung
Andreew, A. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-9717
Huntingtin-Associated Proteins
MacDonald, M. E., Passani, L. A., & Hilditch-Maguire, P. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_15
Self-citationThe clinical utility of multidisciplinary rehabilitation in individuals with Huntington’s Disease
Cruickshank, T. M. (2015) · Research Online (Edith Cowan University)
Investigating oligodendrocyte dysfunction in Huntington's Disease using oligocortical organoids
Witt, S. I. (2025) · cIRcle (University of British Columbia) · doi:10.14288/1.0444027
Regulation of n-type calcium channels by cysteine string protein and huntingtin
Swayne, L. A. (2005) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/91
Role of Striatal Afferents in Evolution of an Animal Model of Huntington's Disease
Boutet, A. (2014) · eScholarship@McGill (McGill) · doi:10.13140/rg.2.2.25548.05764
Bensalel, J., Xu, H., Lu, M. L., Capobianco, E., & Wei, J. (2021) · Figshare · doi:10.6084/m9.figshare.14903735
The potential of neural stem cell progeny in the injured striatum
Andersen, L. B. (2005) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/303
Analysis of the role of arginine methylation in the pathogenesis of Huntington?s disease
Migazzi, A. (2019) · Iris (University of Trento) · doi:10.15168/11572_242962
Dominguez Martinez, M. (2023) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/26405
Ludlam, A. (2023) · Aston Publications Explorer (Aston University) · doi:10.48780/publications.aston.ac.uk.00046007
Études de la propagation de la protéine huntingtine mutée
Gosset, P. (2020) · Corpus Université Laval (Université Laval)
Linkage analysis in corneal stromal dystrophy type 1
Ray, R. (1996) · Mspace (University of Manitoba)
The role of proteasomal complexes in the neurodegenerative Huntington’s disease
Aladdin, A. (2021) · University of Debrecen Electronic Archive (University of Debrecen)
A Role for Cytoskeletal Proteins as Modifiers of Mutant Huntingtin Toxicity
Zahed, H. (2014) · eScholarship (California Digital Library)
Chaurette, J. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
de Pril, R. (2011) · Leiden Repository (Leiden University)
M'Barek, K. B., Orvoen, S., Pla, P., Benstaali, C., Godin, J. D., Gardier, A. M., Saudou, F., David, D. J. P., & Humbert, S. (2012) · ORBi (University of Liège)
Waldo, J. J. (2024) · eScholarship (California Digital Library)
Mechanisms and efficacy of immunomodulatory therapies
Reick, C. (2013) · Dokumentenrepositorium der RUB (Ruhr University Bochum)
Solés-Tarrés, I. (2023) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Contributions of the Thalamus to Striatal Pathology and Motor Dysfunction in Huntington’s Disease
Crevier‐Sorbo, G. (2020) · eScholarship@McGill (McGill) · doi:10.82308/2601
The impact of FAN1 on a CRISPR-Cas9 gene editing approach for Huntington’s Disease
Heraty, L. (2023) · ORCA Online Research @Cardiff (Cardiff University)
Masnata, M. (2021) · Corpus Université Laval (Université Laval)
Euler, P. (2012) · FreiDok plus (Universitätsbibliothek Freiburg)
Characterization and treatment of mouse models of Huntington disease
Van Raamsdonk, J. M. (2005) · cIRcle (University of British Columbia)
Unravelling the contribution of small non-coding RNAs to Huntington’s disease pathogenesis
Guisado Corcoll, A. (2023) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Cuoco, L. T., Gill, S. E., Francois, L., Souders, S., DeMasi, C., Moore, J. R., & Chain, F. J. J. (2026) · BMC Molecular and Cell Biology · doi:10.1186/s12860-026-00570-2
Abnormal cortical development sets the stage in Huntington disease
Degennaro, M., Humbert, S., & Capizzi, M. (2026) · Journal of Huntington s Disease · doi:10.1177/18796397261426033
Mena, D. T. D. S. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Orvoën, S. (2012) · theses.fr (ABES) · doi:10.70675/fc4072b8z23c7z4c2bzb5adz05babcfc2144
Molina-Calavita, M. (2012) · theses.fr (ABES) · doi:10.70675/1110d68az1ccdz4ae1zac88ze9fea888995c
Troubles hormonaux et leur implication dans la progression de la maladie de Huntington
Saleh, N. (2009) · theses.fr (ABES) · doi:10.70675/082f2f5fzb60fz4183za5d2z91bba74ee6d7
Huntington disease and breast cancer
Sousa, C. M. (2013) · theses.fr (ABES) · doi:10.70675/ca2dba2dz3cf6z43a1za914z5505fc3f987c
Étude de la toxicité du peptide amyloïde beta Aß42 dans la levure Saccharomyces cerevisiae
Vignaud, H. (2013) · theses.fr (ABES) · doi:10.70675/6302176az9bd5z4c38zbe9fzd5ea83654ddc
Binding and internalization of exogenous protein assemblies by mammalian cells
Ruiz-Arlandis, G. (2015) · theses.fr (ABES) · doi:10.70675/437e0532ze4e1z4966z80e5z340b6fd3c49d
Trafficking Regulation and Energetics
Rivas, M. V. H. (2014) · theses.fr (ABES) · doi:10.70675/5ffde918zb7aaz4749z8ad1ze7a28ef65de9
Modification des activités de réseaux in vivo chez un modèle murin de la maladie de Huntington
Cabanas, M. (2016) · theses.fr (ABES) · doi:10.70675/f6e1d191z31bcz4630zbda6z678640fa9bb2
Marquilly, C. (2017) · theses.fr (ABES) · doi:10.70675/8b23de8ez3a34z4345z8ecbz57e949043e57
Reconstitution du réseau corticostriatal et cible thérapeutique dans la maladie de Huntington
Virlogeux, A. (2018) · theses.fr (ABES) · doi:10.70675/92b9e042zfafcz42e8z890bz6c7ca43e2613
Imbert, M. (2017) · theses.fr (ABES) · doi:10.70675/deaacc1cz90f4z40b3zbb00z95316d910ff9
Déficits développementaux du circuit striatal chez des modèles murins de la maladie de Huntington
Lebouc, M. (2023) · theses.fr (ABES) · doi:10.70675/f136158dz8184z4417z99f6z6f1479f2dcbe
Premature aging of neural stem cells in Huntington's disease
Lafage, C. (2025) · theses.fr (ABES) · doi:10.70675/633d7238z8475z4623zbec7zec43995b4cb4
Maladie de Huntington : huntingtine, connectivité neuronale et métabolisme oxydatif
Capellano, L. (2025) · theses.fr (ABES) · doi:10.70675/dd0b8f65z490fz446fz8d1azd0dd5619a044
Nicoara, C., Criscuolo, E., Cristofaro, A. D., Fezza, F., & Maccarrone, M. (2026) · Molecules · doi:10.3390/molecules31111965
Fragile polyQ assemblies cause Golgipathy in Huntington’s diseasePreprint
Ma, L., Chen, X., Liu, Y., Dai, L., Ye, F., Yang, W., Buhe, H., Ma, J., Song, C., Li, L., et al. (2026) · eLife · doi:10.7554/elife.111495
Fragile polyQ assemblies cause Golgipathy in Huntington’s diseasePreprint
Ma, L., Chen, X., Liu, Y., Dai, L., Ye, F., Yang, W., Buhe, H., Ma, J., Song, C., Li, L., et al. (2026) · eLife · doi:10.7554/elife.111495.1
Huntingtin is a cell-autonomous regulator of neuropeptide trafficking and clock outputPreprint
Bruno-Vignolo, A., Arnaiz, C., Fernández-Chiappe, F., Ricciuti, A., Duarte, L. A., Ducrey, I., Linenberg, I. M., Pollak, C., Ballestero, P. L., Propato-Lots, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.22.740122
Greco, T. M., Hutton, J. E., Justice, J., Reed, T. J., Vogt, T., Prasad, B. C., & Cristea, I. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.28.741339
Hepatic huntingtin loss drives an acute phase response and liver injury in multiple mouse modelsPreprint
Samstag, C. L., Bragg, R. M., Neumann, K., Mathews, E. W., Lam, K., Wu, C. C., Marchionini, D. M., MacCoss, M. J., Raftery, D., & Carroll, J. B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.28.741358
Herdman, N., Moradi, K., Nmezi, B., Munir, A., Magtoto, K., Liu, F., Sullivan, M. L. G., Zeng, X., Karikari, T. K., & Padiath, Q. S. (2026) · JCI Insight · doi:10.1172/jci.insight.207889
Neuron-derived SPP1 instructs microglia to limit degeneration
Li, S., & Jakobs, T. (2026) · Science Advances · doi:10.1126/sciadv.aee4940
Gene therapy in Huntington’s disease (HD)
Tirgar, F., Hosseini, M., Alijanpour, S., Aghanoori, M.-R., Alijanpour, S., & Mahdavinataj, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00011-7
Investigating the role of Pin1 and Rrs1 in Huntington's Disease
Carnemolla, A. (2008) · SDL
Tardif-Kunk, M. (2026) · ODU Digital Commons (Old Dominion University) · doi:10.25777/0rfe-kk13
Wang, T., Ji, C., & Zhao, T. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1967704
Dinamarca, M. C., Colombo, L., Tousiaki, N. E., Müller, M., & Pecho-Vrieseling, E. (2022) · doi:10.3389/fmolb.2022.916019.s002
Validation of HDAC6 and SIRT2 tubulin deacetylases as therapeutic targets for Huntington's disease
Bobrowska, A. (2012) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Huntingtin Nuclear Localization: Current Insights into Mechanism and Regulation
Desmond, C. R. (2013) · MacSphere (McMaster University) · doi:10.71548/9066
Khan, Z. A. (2012) · Research Online (Edith Cowan University)
Pfister, E. L. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/a5gf-1e13
Scarafone, N. (2012) · ORBi (University of Liège)
The role of protein aggregation in Huntington's disease.
Didszun, C. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Terapia celular en modelos de la enfermedad de Huntington
Pita, M. B. (2005) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Interrogating the role of splicing factors in Huntington’s Disease
Kooner, G. S. (2015) · Figshare
Transgenic Rodent Models of Huntington Disease
Schilling, G., Ross, C. A., & Borchelt, D. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50027-x
Cabré, L. R. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Metadata
- Authors
- Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Mount Sinai Hospital (CA)
- Corresponding author
- MacDonald, Marcy E.
- Venue
- Science
- Published
- 1995-07-21
- Volume
- 269
- Issue
- 5222
- Pages
- 407-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2002644780
- Cited by
- 723
- References
- 29
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 15 · 2023: 16 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 21 · 2014: 33 · 2013: 22 · 2012: 32
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 16367, NS32765, R01NS032765)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Huntington's disease, huntingtin, gene targeting, embryonic lethality, gastrulation, loss of function, gain-of-function, CAG repeat expansion, mouse model, neurodegeneration
- MeSH terms
- Huntingtin Protein, Animals, Base Sequence, Cell Line, Ectoderm, Female, Embryonic and Fetal Development, Genotype, Heterozygote, Homozygote, Humans, Huntington Disease, Male, Mesoderm, Mice, Inbred C57BL, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Phenotype, Stem Cells, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.